• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    6/26/23 12:31:48 PM ET
    $ATUS
    $AVTX
    $BBLN
    $BLTE
    Cable & Other Pay Television Services
    Telecommunications
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ATUS alert in real time by email

    Gainers

    • Benitec Biopharma Inc. (NASDAQ:BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular Dystrophy.
    • TRxADE HEALTH, Inc. (NASDAQ:MEDS) shares jumped 91.9% to $16.20. TRxADE HEALTH issued correction to press release announcing its anticipated combination with Superlatus, Inc.
    • MoonLake Immunotherapeutics (NASDAQ:MLTX) gained 75% to $45.50 after the company's Phase 2 study for Nanobody sonelokimabint met its primary endpoint in hidradenitis suppurativa.
    • INVO Bioscience, Inc. (NASDAQ:INVO) shares jumped 41% to $0.2327 after dropping 5% on Friday.
    • iMedia Brands, Inc. (NASDAQ:IMBI) gained 35% to $0.1891. iMedia Brands announced receipt of second Nasdaq non-compliance notice.
    • Acelyrin, Inc. (NASDAQ:SLRN) shares climbed 35% to $23.81.
    • Digital Media Solutions, Inc. (NYSE:DMS) shares gained 26% to $0.4234 after gaining around 5% on Friday. Digital Media Solutions recently reported slightly worse-than-expected Q1 sales results.
    • BioRestorative Therapies, Inc. (NASDAQ:BRTX) jumped 24.6% to $7.13.
    • Whole Earth Brands, Inc. (NASDAQ:FREE) climbed 21.6% to $3.7932 after a 13D filing showed Martin Franklin delivered a non-binding proposal to Mr. Irwin Simon, the Executive Chairman of the board of directors of Whole Earth, to acquire the company for $4 per share in cash.
    • Kubient, Inc. (NASDAQ:KBNT) surged 17.7% to $0.5650.
    • ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) rose 17% to $7.59. ORIC Pharmaceuticals announced $85 million private placement financing.
    • Identiv, Inc. (NASDAQ:INVE) gained 15.7% to $8.31. B. Riley Securities upgraded Identiv from Neutral to Buy and raised the price target from $10 to $11.
    • Better Choice Company Inc. (NYSE:BTTR) climbed 15.6% to $0.2474.
    • SL Green Realty Corp. (NYSE:SLG) gained 15.5% to $27.19.
    • SQZ Biotechnologies Company (NYSE:SQZ) shares gained 15% to $0.46 after dropping around 23% on Friday.
    • Super League Gaming, Inc. (NASDAQ:SLGG) rose 13.8% to $0.4498.
    • Lucid Group, Inc. (NASDAQ:LCID) gained 13% to $6.18 after the company announced a technology partnership with Aston Martin to integrate, supply Lucid's electric vehicle powertrain and battery systems in contracts worth in excess of $450 million.
    • Altice USA, Inc. (NYSE:ATUS) jumped 11.7% to $2.38.
    • Femasys Inc. (NASDAQ:FEMY) gained 11.2% to $0.6799 after the company announced FDA approval of its IDE for the pivotal clinical trial of FemBloc permanent birth control, a non-surgical alternative for women.
    • IonQ, Inc. (NYSE:IONQ) rose 10.1% to $10.32. Needham maintained IonQ with a Buy and raised the price target from $9 to $11.
    • PacWest Bancorp (NASDAQ:PACW) gained 10% to $7.95 after Ares Management acquired the bank's $3.5 billion specialty finance loan portfolio.
    • Canopy Growth Corporation (NASDAQ:CGC) rose 9.1% to $0.5651.
    • IronNet, Inc. (NYSE:IRNT) climbed 8.6% to $0.2255.
    • CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) jumped 8.6% to $8.62 after the company announced it achieved a milestone and will received $10 million from AbbVie in accordance with its regenerative dermal filler product collaboration agreement.
    • Bruush Oral Care Inc. (NASDAQ:BRSH) shares climbed 8.3% to $0.3303 after declining around 4% on Friday.
    • Belite Bio, Inc (NASDAQ:BLTE) gained 8% to $12.18.
    • Genesco Inc. (NYSE:GCO) climbed 7.3% to $25.68. Genesco said its board of directors had authorized a $50 million increase to its existing $200 million share repurchase authorization.

    Losers

    • Avalo Therapeutics, Inc. (NASDAQ:AVTX) shares dipped 85.7% to $0.6333 after the company's Phase 2 Peak trial For quisovalimab In patients With non-eosinophilic asthma missed its primary endpoint
    • FibroGen, Inc. (NASDAQ:FGEN) dipped 80% to $3.2098 after the company's Phase 3 ZEPHYRUS-1 trial of pamrevlumab failed to meet its primary endpoint in idiopathic pulmonary fibrosis patients.
    • Hitek Global Inc. (NASDAQ:HKIT) fell 23.8% to $4.11.
    • Surgalign Holdings, Inc. (NASDAQ:SRGA) fell 22.4% to $0.2170 after jumping over 38% on Friday. Surgalign received NASDAQ delisting notice following Chapter 11 filing.
    • Super Group (SGHC) Limited (NASDAQ:SGHC) dipped 19.6% to $3.0650. Super Group joined Russell 2000 Index.
    • GSR II Meteora Acquisition Corp. (NASDAQ:GSRM) dropped 18.1% to $5.61.
    • OneConnect Financial Technology Co., Ltd. (NYSE:OCFT) fell 17.4% to $3.3858.
    • Nikola Corporation (NASDAQ:NKLA) dropped 17% to $1.0650.
    • Lulu's Fashion Lounge Holdings, Inc. (NASDAQ:LVLU) fell 16.2% to $2.63 after jumping 48% on Friday.
    • Lion Group Holding Ltd. (NASDAQ:LGHL) dropped 15.8% to $0.1219.
    • Nauticus Robotics, Inc. (NASDAQ:KITT) fell 15.7% to $1.94. Nauticus Robotics announced inclusion in Russell Microcap® Index.
    • Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) dropped 15.2% to $0.2094.
    • Diversified Healthcare Trust (NASDAQ:DHC) fell 14.6% to $1.69. Diversified Healthcare Trust issued monthly SHOP performance update.
    • Biomea Fusion, Inc. (NASDAQ:BMEA) dropped 15.3% to $25.98 after the company announced new clinical data from the first two cohorts of Phase 2 portion of its ongoing Phase 1/2 study of BMF-219 in type 2 diabetes patients.
    • Doma Holdings Inc. (NYSE:DOMA) fell 14.4% to $0.1908.
    • Bio-Path Holdings, Inc. (NASDAQ:BPTH) dropped 13.4% to $1.80.
    • Intapp, Inc. (NASDAQ:INTA) dropped 12.7% to $41.19.
    • Skillz Inc. (NYSE:SKLZ) fell 12% to $8.29.
    • Scholar Rock Holding Corporation (NASDAQ:SRRK) dropped 11.7% to $7.93.
    • Sify Technologies Limited (NASDAQ:SIFY) tumbled 11.4% to $1.63.
    • Carnival Corporation (NYSE:CCL) fell 9% to $14.38 after the company reported second-quarter financial results and issued guidance.
    • Mercury Systems, Inc. (NASDAQ:MRCY) shares dropped 8.2% to $31.97 after the company said it reviewed strategic alternatives and decided to pursue a standalone strategy which includes finding a new CEO.
    • SCWorx Corp. (NASDAQ:WORX) fell 7.6% to $0.4825 after jumping 45% on Friday.
    • Bit Brother Limited (NASDAQ:BTB) fell 7.4% to $0.63 after gaining around 24% on Friday.
    • Babylon Holdings Limited (NYSE:BBLN) fell 7.2% to $0.7149 after surging 24% on Friday. Babylon agreed to be acquired by AlbaCore Capital, MindMaze Group.

     

    Now Read This: Bitcoin, Ethereum Record Gains; NEAR Protocol Emerges As Top Gainer

    Get the next $ATUS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATUS
    $AVTX
    $BBLN
    $BLTE

    CompanyDatePrice TargetRatingAnalyst
    MoonLake Immunotherapeutics
    $MLTX
    3/19/2026$40.00Neutral → Buy
    Rothschild & Co Redburn
    Carnival Corporation
    $CCL
    3/19/2026$31.00Equal-Weight → Overweight
    Morgan Stanley
    Lucid Group Inc.
    $LCID
    3/18/2026$17.00Buy
    Citigroup
    SL Green Realty Corp
    $SLG
    3/18/2026$44.00Hold → Buy
    Deutsche Bank
    Lucid Group Inc.
    $LCID
    3/4/2026$10.00Underperform
    BofA Securities
    Avalo Therapeutics Inc.
    $AVTX
    2/2/2026$50.00Buy
    Guggenheim
    Belite Bio Inc
    $BLTE
    1/26/2026$195.00Buy
    BofA Securities
    MoonLake Immunotherapeutics
    $MLTX
    1/15/2026$10.00Neutral → Sell
    Goldman
    More analyst ratings

    $ATUS
    $AVTX
    $BBLN
    $BLTE
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Femasys Inc.

    SCHEDULE 13G - FEMASYS INC (0001339005) (Subject)

    3/18/26 5:00:01 PM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    Canopy Growth Corporation filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Canopy Growth Corp (0001737927) (Filer)

    3/16/26 7:59:07 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Hitek Global Inc.

    6-K - HiTek Global Inc. (0001742341) (Filer)

    3/13/26 4:05:02 PM ET
    $HKIT
    Computer Software: Prepackaged Software
    Technology

    $ATUS
    $AVTX
    $BBLN
    $BLTE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MoonLake Immunotherapeutics upgraded by Rothschild & Co Redburn with a new price target

    Rothschild & Co Redburn upgraded MoonLake Immunotherapeutics from Neutral to Buy and set a new price target of $40.00

    3/19/26 8:23:34 AM ET
    $MLTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Carnival upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Carnival from Equal-Weight to Overweight and set a new price target of $31.00

    3/19/26 8:22:53 AM ET
    $CCL
    Marine Transportation
    Consumer Discretionary

    Citigroup initiated coverage on Lucid Group with a new price target

    Citigroup initiated coverage of Lucid Group with a rating of Buy and set a new price target of $17.00

    3/18/26 8:56:23 AM ET
    $LCID
    Auto Manufacturing
    Industrials

    $ATUS
    $AVTX
    $BBLN
    $BLTE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Teuber William J Jr bought $115,155 worth of shares (3,000 units at $38.38), increasing direct ownership by 47% to 9,413 units (SEC Form 4)

    4 - IonQ, Inc. (0001824920) (Issuer)

    2/27/26 9:55:03 PM ET
    $IONQ
    EDP Services
    Technology

    Director Suvretta Capital Management, Llc bought $1,903,133 worth of shares (144,223 units at $13.20) (SEC Form 4)

    4 - Benitec Biopharma Inc. (0001808898) (Issuer)

    12/29/25 7:31:28 PM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Suvretta Capital Management, Llc bought $538,972 worth of shares (46,141 units at $11.68) (SEC Form 4)

    4 - Benitec Biopharma Inc. (0001808898) (Issuer)

    12/22/25 7:45:03 PM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ATUS
    $AVTX
    $BBLN
    $BLTE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease

    New blinded data from ~45 patients to date in key pain and function scales and safety and tolerability of the Company's proprietary hypoxic-cultured mesenchymal stem cells to be unveiled on March 28th at the 2026 Orthopaedic Research Society Annual Meeting MELVILLE, N.Y., March 19, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative," "BRTX," or the "Company") (NASDAQ:BRTX), a late-stage clinical regenerative medicine company focused on stem cell-based therapies and products, today announced that new blinded data on approximately 45 patients from its Phase 2 clinical trial evaluating hypoxic-cultured mesenchymal stem cells for the treatment of chronic lumbar disc dise

    3/19/26 8:00:00 AM ET
    $BRTX
    Managed Health Care
    Health Care

    SL Green Refinances Corporate Credit Facility

    NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE:SLG), Manhattan's largest office landlord, today announced that it has refinanced, extended and reduced the overall cost of $2.0 billion of its $2.4 billion corporate credit facility. The existing revolving line of credit component of the facility has been maintained at $1.25 billion, the maturity date has been extended to June 2031, inclusive of as-of-right extension options, and the borrowing cost was reduced by 25 basis points to 125 basis points over SOFR based on the Company's current credit rating.   The existing $1.05 billion term loan component of the facility has been bifurcated, resulting in a new $750 mill

    3/19/26 7:30:00 AM ET
    $SLG
    Real Estate Investment Trusts
    Real Estate

    CollPlant Biotechnologies Launches Redesigned Corporate Website

    REHOVOT, Israel, March 18, 2026 /PRNewswire/ -- CollPlant (NASDAQ:CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary plant-derived recombinant human collagen (rhCollagen), today announced the launch of its redesigned corporate website at www.collplant.com. The new website provides expanded information regarding the Company's technology platform, product pipeline, strategic collaborations and corporate governance, and is intended to enhance transparency and accessibility for investors, partners, and other

    3/18/26 9:00:00 AM ET
    $CLGN
    Industrial Specialties
    Health Care

    $ATUS
    $AVTX
    $BBLN
    $BLTE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Ross Kirsty Farrah

    3 - Super Group (SGHC) Ltd (0001878057) (Issuer)

    3/18/26 8:48:15 PM ET
    $SGHC
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form 3 filed by new insider Jossel Jonathan Robert

    3 - Super Group (SGHC) Ltd (0001878057) (Issuer)

    3/18/26 8:45:26 PM ET
    $SGHC
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form 3 filed by new insider Nathan Martine

    3 - Super Group (SGHC) Ltd (0001878057) (Issuer)

    3/18/26 8:42:38 PM ET
    $SGHC
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $ATUS
    $AVTX
    $BBLN
    $BLTE
    Leadership Updates

    Live Leadership Updates

    View All

    Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors

    ATLANTA, March 18, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today the appointment of Kenneth D. Eichenbaum, M.D., M.S.E., to its Board of Directors. Dr. Eichenbaum is a board-certified anesthesiologist with clinical affiliations at Corewell Health William Beaumont University Hospital and Trinity Health Oakland Hospital, bringing deep clinical expertise and strategic insight developed through more than 20 years of evaluating biotechnology and medical device companies and advising investment firms. He completed a fel

    3/18/26 9:00:00 AM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    Canopy Growth Completes Acquisition of MTL Cannabis Creating Canada's Leading Medical Cannabis Business By Revenue

    This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024 All financial amounts in this press release are expressed in Canadian dollars. Strengthens Canopy Growth's core Canadian platform, providing additional high-quality flower to support international growth Expected run-rate synergies of approximately $10 million within 18 months Canopy Growth's leadership team and operational depth strengthened through addition of MTL management team members Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) and MTL Cannab

    3/16/26 7:41:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Princess Cruises Announces 2028 World Cruise: 115-Day Global Voyage Visiting 49 Destinations Onboard Coral Princess

    See the World, Unpack Once: 2028 World Cruise Features Maiden Call to Mossel Bay, South Africa and Expanded More Ashore ExperiencesFORT LAUDERDALE, Fla., March 10, 2026 /PRNewswire/ -- Princess Cruises announces its spectacular 2028 World Cruise onboard Coral Princess, a 115-day, globe-spanning journey to 49 destinations across 24 countries and five continents - featuring 39 UNESCO World Heritage Sites, more overnight and late-night stays, and a maiden call to Mossel Bay, South Africa, on sale today. Departing January 3, 2028, roundtrip from Fort Lauderdale, or Los Angeles, the

    3/10/26 2:30:00 PM ET
    $CCL
    $CUK
    Marine Transportation
    Consumer Discretionary

    $ATUS
    $AVTX
    $BBLN
    $BLTE
    Financials

    Live finance-specific insights

    View All

    SL Green Refinances Corporate Credit Facility

    NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE:SLG), Manhattan's largest office landlord, today announced that it has refinanced, extended and reduced the overall cost of $2.0 billion of its $2.4 billion corporate credit facility. The existing revolving line of credit component of the facility has been maintained at $1.25 billion, the maturity date has been extended to June 2031, inclusive of as-of-right extension options, and the borrowing cost was reduced by 25 basis points to 125 basis points over SOFR based on the Company's current credit rating.   The existing $1.05 billion term loan component of the facility has been bifurcated, resulting in a new $750 mill

    3/19/26 7:30:00 AM ET
    $SLG
    Real Estate Investment Trusts
    Real Estate

    CARNIVAL CORPORATION & PLC TO HOLD CONFERENCE CALL ON FIRST QUARTER EARNINGS

    MIAMI, March 17, 2026 /PRNewswire/ -- Carnival Corporation & plc ((NYSE/LSE: CCL, NYSE:CUK) has scheduled a conference call with analysts for Friday, March 27, 2026, at 10 a.m. (EDT); 2 p.m. (GMT) to discuss the company's first quarter financial results which are expected to be released that morning. A simulcast of the call will be available via the company's websites at www.carnivalcorp.com and www.carnivalplc.com.About Carnival Corporation & plc Carnival Corporation & plc is the largest global cruise company, and among the largest leisure travel companies, with a portfolio of world-class cruise lines – AIDA Cruises, Carnival Cruise Line, Costa Cruises, Cunard, Holland America Line, P&O Cru

    3/17/26 9:15:00 AM ET
    $CCL
    $CUK
    Marine Transportation
    Consumer Discretionary

    SL Green Realty Corp. to Release First Quarter 2026 Financial Results after Market Close on April 15, 2026

    NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE:SLG), Manhattan's largest office landlord, today announced that it will release its earnings for the first quarter of 2026 on Wednesday, April 15, 2026 after market close. The Company's executive management team, led by Marc Holliday, Chairman and Chief Executive Officer, will host a conference call and audio webcast on Thursday, April 16, 2026 at 2:00pm ET to discuss the financial results. Simultaneous with the earnings release, supplemental data will be made available in the Investors section of the SL Green Realty Corp. website at https://slgreen.com under "Financial Reports". The live conference call will be we

    3/17/26 7:30:00 AM ET
    $SLG
    Real Estate Investment Trusts
    Real Estate

    $ATUS
    $AVTX
    $BBLN
    $BLTE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Pieris Pharmaceuticals Inc.

    SC 13G/A - PALVELLA THERAPEUTICS, INC. (0001583648) (Subject)

    12/17/24 5:42:35 PM ET
    $PIRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Skillz Inc.

    SC 13D/A - Skillz Inc. (0001801661) (Subject)

    12/12/24 4:01:36 PM ET
    $SKLZ
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Benitec Biopharma Inc.

    SC 13G/A - Benitec Biopharma Inc. (0001808898) (Subject)

    12/6/24 1:47:28 PM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care